Catheter ablation of atrial fibrillation: is the burn worth the buck?
N A Mark
NA
Estes
D000889:Anti-Arrhythmia Agents / Q000191:economics* / Q000627:therapeutic use*; D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D017115:Catheter Ablation / Q000191:economics* / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics / Q000706:statistics & numerical data; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D038622:Internationality; D015995:Prevalence
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants